Image: IANS

Covaxin has no serious side effects, says Lancet

Hyderabad: Covaxin, India’s first indigenous vaccine for Covid-19, is “safe, immunogenic with no serious side effects”, says leading medical journal The Lancet in its interim efficacy analysis. The Lancet – Infectious Diseases Journal, published phase 2 results of the vaccine developed by Hyderabad-based Bharat Biotech. However, the report made it clear that efficacy cannot be determined […]

𝑰𝒎𝒂𝒈𝒆 𝑪𝒓𝒆𝒅𝒊𝒕: 𝑰𝑨𝑵𝑺

Telangana: Couple names son after actor-philanthropist Sonu Sood

Hyderabad: Impressed by actor Sonu Sood’s philanthropic work, a couple in Telangana has named their son after him. Pandaga Naveen Kumar and his wife Triveni of Khammam district named their child born during Covid-19 induced lockdown, after Sonu Sood. The couple Mustikunta village of Bonakal mandal in the district organised Annaprasana, a ritual to mark the […]

𝐏𝐡𝐨𝐭𝐨: 𝐈𝐀𝐍𝐒

13,000 volunteers given 2nd dose of Covaxin: Bharat Biotech

Hyderabad (3 Min Read): Bharat Biotech on Friday announced that 13,000 volunteers have been successfully administered the second dose of its Covid vaccine Covaxin in the phase-3 trials. Suchitra Ella, Joint Managing Director, Bharat Biotech International Limited, thanked the volunteers for their pro-vaccine public health volunteerism. The announcement came amid the continuing administration of Covaxin in […]

𝐑𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐦𝐚𝐠𝐞

Healthcare worker in Telangana dies hours after getting Covid jab, govt says not linked to vaccine

Hyderabad: A healthcare worker in Telangana, who was vaccinated for Covid-19 on Tuesday, died on Wednesday but authorities said the death seems unrelated to the vaccine. Director of Public Health and Family Welfare, Dr G. Srinivas Rao, said that the healthcare worker was given the jab of Covid vaccine on Tuesday at around 11.30 a.m. at […]

Representational Image | Pixabay

Dr Reddy’s receives approval for Phase 3 clinical trial of Sputnik vaccine

Hyderabad: Pharma major Dr Reddy’s Laboratories Ltd on Friday announced that it has received approval from the Drugs Control General of India (DCGI) to conduct Phase 3 clinical trial for the Sputnik V vaccine in India. The Phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomised, double-blind, parallel-group, […]